相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ibrexafungerp: A novel oral glucan synthase inhibitor
M. R. Davis et al.
MEDICAL MYCOLOGY (2020)
Posaconazole Serum Drug Levels Associated With Pseudohyperaldosteronism
Minh-Vu H. Nguyen et al.
CLINICAL INFECTIOUS DISEASES (2020)
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
J. Peter Donnelly et al.
CLINICAL INFECTIOUS DISEASES (2020)
Open-Label Crossover Oral Bioequivalence Pharmacokinetics Comparison for a 3-Day Loading Dose Regimen and 15-Day Steady-State Administration of SUBA-Itraconazole and Conventional Itraconazole Capsules in Healthy Adults
George R. Thompson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Pharmacokinetics and Pharmacodynamics of Posaconazole
Lu Chen et al.
DRUGS (2020)
Invasive Pulmonary Aspergillosis in Adults With Avian Influenza A (H7N9) Pneumonia in China: A Retrospective Study
Pengfei Zou et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Influenza-Associated Aspergillosis Nationwide Trends, Predictors and Outcomes From 2005 to 2014
Aditi Sharma et al.
CHEST (2020)
Aspergillus fumigatusand pan-azole resistance: who should be concerned?
Nathan P. Wiederhold et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2020)
Fungal Infections Potentiated by Biologics
Matthew R. Davis et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2020)
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
Paul E. Verweij et al.
INTENSIVE CARE MEDICINE (2020)
Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19
George R. Thompson et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Breakthrough invasive fungal infections: Who is at risk?
Jeffrey D. Jenks et al.
MYCOSES (2020)
Management of posaconazole-induced pseudohyperaldosteronism
Matthew R. Davis et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Invasive pulmonary aspergillosis in immunocompetent patients hospitalised with influenza A-related pneumonia: a multicenter retrospective study
Liang Chen et al.
BMC PULMONARY MEDICINE (2020)
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
Philipp Koehler et al.
LANCET INFECTIOUS DISEASES (2020)
Itraconazole induced hypertension and hypokalemia: Mechanistic evaluation
Wesley J. Hoffmann et al.
MYCOSES (2018)
Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study
Alexander F. A. D. Schauwvlieghe et al.
LANCET RESPIRATORY MEDICINE (2018)
Effects of Food and Omeprazole on a Novel Formulation of Super Bioavailability Itraconazole in Healthy Subjects
Julian Lindsay et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Real-Life Assessment of the Safety and Effectiveness of the New Tablet and Intravenous Formulations of Posaconazole in the Prophylaxis of Invasive Fungal Infections via Analysis of 343 Courses
Frank P. Tverdek et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
Thomas F. Patterson et al.
CLINICAL INFECTIOUS DISEASES (2016)
Invasive Aspergillosis Current Strategies for Diagnosis and Management
Jose Cadena et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2016)
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
Johan A. Maertens et al.
LANCET (2016)
Combination Antifungal Therapy for Invasive Aspergillosis A Randomized Trial
Kieren A. Marr et al.
ANNALS OF INTERNAL MEDICINE (2015)
Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing
P. Lewis White et al.
CLINICAL INFECTIOUS DISEASES (2015)
Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent
Marisa H. Miceli et al.
CLINICAL INFECTIOUS DISEASES (2015)
What's new in antifungals: an update on the in-vitro activity and in-vivo efficacy of new and investigational antifungal agents
Nathan P. Wiederhold et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2015)
Analytical and Clinical Evaluation of the PathoNostics AsperGenius Assay for Detection of Invasive Aspergillosis and Resistance to Azole Antifungal Drugs during Testing of Serum Samples
P. Lewis White et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Application of the 2008 Definitions for Invasive Fungal Diseases to the Trial Comparing Voriconazole Versus Amphotericin B for Therapy of Invasive Aspergillosis: A Collaborative Study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group
Raoul Herbrecht et al.
CLINICAL INFECTIOUS DISEASES (2015)
Prospective Multicenter International Surveillance of Azole Resistance in Aspergillus fumigatus
J. W. M. van der Linden et al.
EMERGING INFECTIOUS DISEASES (2015)
Switching from Posaconazole Suspension to Tablets Increases Serum Drug Levels in Leukemia Patients without Clinically Relevant Hepatotoxicity
Dong Sik Jung et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Serum Galactomannan-Based Early Detection of Invasive Aspergillosis in Hematology Patients Receiving Effective Antimold Prophylaxis
Rafael F. Duarte et al.
CLINICAL INFECTIOUS DISEASES (2014)
A Breath Fungal Secondary Metabolite Signature to Diagnose Invasive Aspergillosis
Sophia Koo et al.
CLINICAL INFECTIOUS DISEASES (2014)
Osteomyelitis caused by Aspergillus species: a review of 310 reported cases
E. Gabrielli et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Approach to invasive pulmonary aspergillosis in critically ill patients
Despoina Koulenti et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2014)
Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
H. Ruth Ashbee et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Treatment of Infections by Cryptic Aspergillus Species
Wagner L. Nedel et al.
MYCOPATHOLOGIA (2014)
Our 2014 approach to breakthrough invasive fungal infections
Georg Maschmeyer et al.
MYCOSES (2014)
Allergic Bronchopulmonary Aspergillosis
Paul A. Greenberger et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2014)
Invasive fungal rhinosinusitis
Praveen Duggal et al.
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2013)
Fungal Disease of the Nose and Sinuses: An Updated Overview
Christopher Chang et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2013)
The Mycotic Ulcer Treatment Trial A Randomized Trial Comparing Natamycin vs Voriconazole
N. Venkatesh Prajna et al.
JAMA OPHTHALMOLOGY (2013)
The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial
Wan Beom Park et al.
CLINICAL INFECTIOUS DISEASES (2012)
Fungal disease of the nose and paranasal sinuses
George R. Thompson et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Aspergillus Tracheobronchitis Report of 8 Cases and Review of the Literature
Mario Fernandez-Ruiz et al.
MEDICINE (2012)
Cryptic Species and Azole Resistance in the Aspergillus niger Complex
Susan J. Howard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Efficacy, Safety, and Breakthrough Infections Associated with Standard Long-Term Posaconazole Antifungal Prophylaxis in Allogeneic Stem Cell Transplantation Recipients
Drew J. Winston et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis
S. Schwartz et al.
INFECTION (2011)
Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients
Livio Pagano et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
The Y238X Stop Codon Polymorphism in the Human β-Glucan Receptor Dectin-1 and Susceptibility to Invasive Aspergillosis
Louis Y. A. Chai et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Pulmonary Aspergillosis: Recent Advances
George R. Thompson et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
The Initial 96 Hours of Invasive Pulmonary Aspergillosis: Histopathology, Comparative Kinetics of Galactomannan and (1→3)-β-D-Glucan, and Consequences of Delayed Antifungal Therapy
William W. Hope et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Geoclimatic Influences on Invasive Aspergillosis after Hematopoietic Stem Cell Transplantation
Anil A. Panackal et al.
CLINICAL INFECTIOUS DISEASES (2010)
Factors Associated with Mortality in Transplant Patients with Invasive Aspergillosis
John W. Baddley et al.
CLINICAL INFECTIOUS DISEASES (2010)
Efficacy and Safety of Posaconazole for Chronic Pulmonary Aspergillosis
Timothy W. Felton et al.
CLINICAL INFECTIOUS DISEASES (2010)
Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort
J. W. Hiemenz et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2010)
Pharmacology and clinical use of voriconazole
George R. Thompson et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2010)
Prognostic Features of Galactomannan Antigenemia in Galactomannan-Positive Invasive Aspergillosis
Sophia Koo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Isavuconazole: A Comprehensive Review of Spectrum of Activity of a New Triazole
George R. Thompson et al.
MYCOPATHOLOGIA (2010)
Invasive Aspergillosis after Pandemic (H1N1) 2009
Asma Lat et al.
EMERGING INFECTIOUS DISEASES (2010)
Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications
David Andes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Posaconazole Therapeutic Drug Monitoring: a Reference Laboratory Experience
George R. Thompson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry
D. Neofytos et al.
CLINICAL INFECTIOUS DISEASES (2009)
Fungal Infections in Hematopoietic Stem Cell Transplantation and Solid-Organ Transplantation-Focus on Aspergillosis
Marcio Nucci et al.
CLINICS IN CHEST MEDICINE (2009)
An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients
C. Viscoli et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Index to Predict Invasive Mold Infection in High-Risk Neutropenic Patients Based on the Area Over the Neutrophil Curve
Rodrigo D. Portugal et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Discovery of a sexual cycle in the opportunistic fungal pathogen Aspergillus fumigatus
Celine M. O'Gorman et al.
NATURE (2009)
Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis
D. P. Kontoyiannis et al.
TRANSPLANT INFECTIOUS DISEASE (2009)
Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2008)
Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation
Pierre-Yves Bochud et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications
Marisa H. Miceli et al.
CANCER (2007)
Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)
Oliver A. Cornely et al.
CLINICAL INFECTIOUS DISEASES (2007)
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia
Oliver A. Cornely et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease
Andrew J. Ullmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2007)
Nomenclatural considerations in naming species of Aspergillus and its teleomorphs
J. I. Pitt et al.
STUDIES IN MYCOLOGY (2007)
Molecular studies reveal frequent misidentification of Aspergillus fumigatus by morphotyping
S. Arunmozhi Balajee et al.
EUKARYOTIC CELL (2006)
Echinocandins for candidemia in adults without neutropenia
John E. Bennett
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Issues with galactomannan testing
Paul E. Verweij et al.
MEDICAL MYCOLOGY (2006)
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: Impact of other therapies on outcome
TF Patterson et al.
CLINICAL INFECTIOUS DISEASES (2005)
The invasive and saprophytic syndromes due to Aspergillus spp.
WW Hope et al.
MEDICAL MYCOLOGY (2005)
The radiological spectrum of pulmonary aspergillosis
R Greene
MEDICAL MYCOLOGY (2005)
Aspergillus infections in transplant recipients
N Singh et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Invasive aspergillosis in critically ill patients without malignancy
W Meersseman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
β-D-glucan as a diagnostic adjunct for invasive fungal infections:: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome
Z Odabasi et al.
CLINICAL INFECTIOUS DISEASES (2004)
Chronic cavitary and Fibrosing pulmonary and pleural aspergillosis: Case series, proposed nomenclature change, and review
DW Denning et al.
CLINICAL INFECTIOUS DISEASES (2003)
The isolation of Aspergillus fumigatus from respiratory tract specimens in heart transplant recipients is highly predictive of invasive aspergillosis
P Muñoz et al.
TRANSPLANTATION (2003)
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
R Herbrecht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients
R Herbrecht et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
The impact of culture isolation of Aspergillus species:: A hospital-based survey of aspergillosis
JR Perfect et al.
CLINICAL INFECTIOUS DISEASES (2001)
Mortality and costs of acute renal failure associated with amphotericin B therapy
DW Bates et al.
CLINICAL INFECTIOUS DISEASES (2001)
Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia
D Caillot et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Invasive aspergillosis - Disease spectrum, treatment practices, and outcomes
TF Patterson et al.
MEDICINE (2000)
A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.
DA Stevens et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
